Overview

Efficacy of Letrozole in Recurrent Ovarian Cancer

Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Randomized phase III multicenter study investigating the role of letrozole in heavily pretreated recurrent ovarian cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Treatments:
Letrozole